Support PenkeNovo Nordisk A/S - Trending symbols
Latest News of Novo Nordisk A/S
| Date | Title | Read |
|---|---|---|
| 2025-03-29 19:33 | Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025 | Read |
| 2025-03-29 15:33 | Ozempic® (once-weekly semaglutide 1.0 mg) shown to improve walking distance and quality of life in adults with type 2 diabetes and peripheral artery disease (PAD) at ACC 2025 | Read |
| 2025-03-28 22:45 | Novo Nordisk (NVO) Stock Moves -1.23%: What You Should Know | Read |
| 2025-03-28 22:25 | Is Novo Nordisk (NVO) the Best ADR Stock to Buy According to Hedge Funds? | Read |
| 2025-03-28 17:07 | Novo Nordisk Q1 Earnings Likely to Miss Estimates on Slower Ozempic, Wegovy Sales, BofA Says | Read |
| 2025-03-28 15:09 | Novo Nordisk Inks Its Second Big Obesity Deal In A Week — And It's Not For A GLP-1 | Read |
| 2025-03-28 14:54 | BofA cuts Novo Nordisk shares target on expected Q1 earnings miss | Read |
| 2025-03-28 14:00 | Investors Heavily Search Novo Nordisk A/S (NVO): Here is What You Need to Know | Read |
| 2025-03-27 22:04 | Wegovy sales took a hit this year. Novo's CEO blames off-brand competition | Read |
| 2025-03-27 18:29 | Novo shares on track for biggest monthly fall since 2002, investor worries grow | Read |
Notifications
| Type | Notification | Date |
|---|---|---|
| RSI Oversold | Oversold RSI (Relative Strength Index) | 2025-03-27 |
Trends
| 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Reconciled Depreciation | 400,629 | -10,444 | 390,185 | 794,161 | 1,184,346 | -896,461 | 287,885 | -1,006,125 | -718,240 | |
| Net Interest Income | -58,380 | 31,199 | -27,182 | 3,080 | -24,102 | -18,746 | -42,848 | 87,035 | 44,187 | |
| Interest Expense | 1,076,958 | -926,610 | 150,348 | -112,694 | 37,654 | 252,858 | 290,512 | -572,046 | -281,534 | |
| Interest Income | 428,800 | -314,632 | 114,168 | -27,470 | 86,698 | 357,914 | 444,612 | -822,492 | -377,880 |
Comments
How you think about this?